Free Trial

Biotricity (BTCY) Competitors

Biotricity logo
$0.52 0.00 (0.00%)
As of 11:04 AM Eastern

BTCY vs. APT, SPAI, MODD, TELA, PTHL, MDAI, POCI, ECOR, DXR, and COCH

Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Modular Medical (MODD), TELA Bio (TELA), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Spectral AI (MDAI), Precision Optics (POCI), electroCore (ECOR), Daxor (DXR), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry.

Biotricity vs.

Alpha Pro Tech (NYSE:APT) and Biotricity (NASDAQ:BTCY) are both small-cap industrials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.

In the previous week, Alpha Pro Tech's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company Overall Sentiment
Alpha Pro Tech Neutral
Biotricity Neutral

Alpha Pro Tech received 34 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 100.00% of users gave Alpha Pro Tech an outperform vote while only 0.00% of users gave Biotricity an outperform vote.

CompanyUnderperformOutperform
Alpha Pro TechOutperform Votes
34
100.00%
Underperform Votes
No Votes
BiotricityOutperform Votes
No Votes
Underperform Votes
2
100.00%

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Alpha Pro Tech has a net margin of 6.99% compared to Biotricity's net margin of -80.42%. Alpha Pro Tech's return on equity of 6.70% beat Biotricity's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
Biotricity -80.42%N/A -188.47%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Alpha Pro Tech has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$58.18M0.85$4.19M$0.3712.30
Biotricity$12.06M1.07-$14.09M-$1.08-0.48

Alpha Pro Tech has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.

Summary

Alpha Pro Tech beats Biotricity on 11 of the 14 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTCY vs. The Competition

MetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$12.95M$4.43B$5.33B$8.39B
Dividend YieldN/A43.63%5.21%4.11%
P/E Ratio-0.4829.0826.7119.71
Price / Sales1.0766.76386.13120.55
Price / CashN/A51.0838.2534.62
Price / Book-0.406.196.774.50
Net Income-$14.09M$67.60M$3.23B$248.22M
7 Day Performance26.21%-0.63%1.80%0.56%
1 Month Performance12.43%17.91%11.10%13.17%
1 Year Performance-58.06%21.16%17.11%7.30%

Biotricity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTCY
Biotricity
N/A$0.52
flat
N/A-52.7%$12.95M$12.06M-0.4840
APT
Alpha Pro Tech
N/A$4.58
+1.1%
N/A-10.6%$49.76M$57.84M12.38120Gap Down
SPAI
Safe Pro Group Inc. Common Stock
N/A$3.16
+7.1%
N/AN/A$47.94M$2.17M0.0011Earnings Report
Gap Down
MODD
Modular Medical
0.8663 of 5 stars
$0.99
-3.3%
N/A-48.8%$40.09MN/A-1.8620News Coverage
TELA
TELA Bio
1.8515 of 5 stars
$0.98
-3.0%
$7.25
+639.8%
-77.3%$38.76M$69.30M-0.58120News Coverage
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/A$5.58
+17.2%
N/AN/A$36.73M$448,196.000.0011Analyst Upgrade
High Trading Volume
MDAI
Spectral AI
3.0457 of 5 stars
$1.42
+4.4%
$4.75
+234.5%
-21.6%$35.95M$29.58M-2.1883Analyst Upgrade
Analyst Revision
POCI
Precision Optics
0.6943 of 5 stars
$4.58
flat
N/A-36.3%$35.11M$18.68M-7.1680Earnings Report
Gap Up
ECOR
electroCore
2.1828 of 5 stars
$4.72
-2.1%
$25.50
+440.3%
-27.6%$35.03M$25.18M-2.5850Gap Up
High Trading Volume
DXR
Daxor
3.7982 of 5 stars
$7.20
-0.8%
$25.00
+247.2%
-19.8%$34.83M$2.13M0.0037Gap Up
COCH
Envoy Medical
1.743 of 5 stars
$1.62
-3.1%
$9.13
+463.3%
-47.5%$34.55M$212,000.00-1.1734Gap Down

Related Companies and Tools


This page (NASDAQ:BTCY) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners